199 related articles for article (PubMed ID: 29133814)
1. Structural remodeling and oligomerization of human cathelicidin on membranes suggest fibril-like structures as active species.
Sancho-Vaello E; François P; Bonetti EJ; Lilie H; Finger S; Gil-Ortiz F; Gil-Carton D; Zeth K
Sci Rep; 2017 Nov; 7(1):15371. PubMed ID: 29133814
[TBL] [Abstract][Full Text] [Related]
2. Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.
Zeth K; Sancho-Vaello E
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068993
[TBL] [Abstract][Full Text] [Related]
3. The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics.
Sancho-Vaello E; Gil-Carton D; François P; Bonetti EJ; Kreir M; Pothula KR; Kleinekathöfer U; Zeth K
Sci Rep; 2020 Oct; 10(1):17356. PubMed ID: 33060695
[TBL] [Abstract][Full Text] [Related]
4. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
5. Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane.
Majewska M; Zamlynny V; Pieta IS; Nowakowski R; Pieta P
Bioelectrochemistry; 2021 Oct; 141():107842. PubMed ID: 34049238
[TBL] [Abstract][Full Text] [Related]
6. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.
Oren Z; Lerman JC; Gudmundsson GH; Agerberth B; Shai Y
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):501-13. PubMed ID: 10417311
[TBL] [Abstract][Full Text] [Related]
7. Primate cathelicidin orthologues display different structures and membrane interactions.
Morgera F; Vaccari L; Antcheva N; Scaini D; Pacor S; Tossi A
Biochem J; 2009 Feb; 417(3):727-35. PubMed ID: 18922132
[TBL] [Abstract][Full Text] [Related]
8. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
Wang G
J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
[TBL] [Abstract][Full Text] [Related]
9. Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37.
Xhindoli D; Pacor S; Guida F; Antcheva N; Tossi A
Biochem J; 2014 Jan; 457(2):263-75. PubMed ID: 24117320
[TBL] [Abstract][Full Text] [Related]
10. A Spectroscopic Study of the Aggregation State of the Human Antimicrobial Peptide LL-37 in Bacterial versus Host Cell Model Membranes.
Bonucci A; Caldaroni E; Balducci E; Pogni R
Biochemistry; 2015 Nov; 54(45):6760-8. PubMed ID: 26502164
[TBL] [Abstract][Full Text] [Related]
11. Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors.
Kulkarni NN; O'Neill AM; Dokoshi T; Luo EWC; Wong GCL; Gallo RL
J Biol Chem; 2021 Jul; 297(1):100828. PubMed ID: 34048712
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
Henzler Wildman KA; Lee DK; Ramamoorthy A
Biochemistry; 2003 Jun; 42(21):6545-58. PubMed ID: 12767238
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
Zaiou M; Nizet V; Gallo RL
J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
[TBL] [Abstract][Full Text] [Related]
14. The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure.
Engelberg Y; Landau M
Nat Commun; 2020 Aug; 11(1):3894. PubMed ID: 32753597
[TBL] [Abstract][Full Text] [Related]
15. Unique features of human cathelicidin LL-37.
Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
[TBL] [Abstract][Full Text] [Related]
16. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
[TBL] [Abstract][Full Text] [Related]
17. The cysteine protease ApdS from
Xie F; Zan Y; Zhang Y; Zheng N; Yan Q; Zhang W; Zhang H; Jin M; Chen F; Zhang X; Liu S
J Biol Chem; 2019 Nov; 294(47):17962-17977. PubMed ID: 31619521
[No Abstract] [Full Text] [Related]
18. Interactions of GF-17 derived from LL-37 antimicrobial peptide with bacterial membranes: a molecular dynamics simulation study.
Aghazadeh H; Ganjali Koli M; Ranjbar R; Pooshang Bagheri K
J Comput Aided Mol Des; 2020 Dec; 34(12):1261-1273. PubMed ID: 33009624
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37.
Henzler-Wildman KA; Martinez GV; Brown MF; Ramamoorthy A
Biochemistry; 2004 Jul; 43(26):8459-69. PubMed ID: 15222757
[TBL] [Abstract][Full Text] [Related]
20. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
